The last two decades have witnessed extraordinary pharmacological and technical advances which have dramatically altered our approach to the management of gall stones. These developments drew the attention of the medical profession and general public alike to the significant morbidity associated with classical cholecystectomy. Nevertheless it remains difficult to define clear indications for many of the alternative treatments, particularly in view of the lack of long-term studies and details not only of procedure-related complications but also of problems associated with the diseased gall bladder being in situ for a prolonged period. The situation is further complicated in some countries where market forces seem to play an inordinate part in the management of this particular problem.
It is neverthless remarkable that the known association between gall stones and the development ofgall bladder cancer has seemed to play such a small part in the decision-making process regarding the treatment of symptomatic gall bladder disease. The aim of this article is to review the alternatives to traditional cholecystectomy in the light ofwhat is presently known about the process leading to carcinoma of the gall bladder. As a reaction to this morbidity the classical incisions gave way in the 1980s to that of the 'minilap' using a 5-cm muscle-splitting incision and a no-touch technique in a 'well'.'7",8 Improving both local and systemic morbidity '9 breathed life into the open cholecystectomy in the face of advances in dissolution therapy and extracorporeal shock-wave lithotripsy.
Open cholecystectomy

Dissolution therapy
It is nearly 20 years since the study from Danzinger et al showed that oral chenodeoxycholic acid could produce cholesterol stone dissolution.20 This report was responsible for stimulating many groups in the confident expectation that non-operative methods for managing gall stones would eventually become firmly established. Consequently, after a number of small studies, a large randomised multicentre study the National Co-operative Study was embarked upon in the US to define in particular the efficacy and indication for chenodeoxycholic acid. The development of 'mother and baby' endoscopes (initially developed for the clearance of stones from the common bile duct26) facilitated the introduction of solvents into the cystic duct. Agents such as methyl-tert-butyl ether will effectively dissolve cholesterol stones27 and this method seems likely to be fraught with less problems than previously attempted percutaneous approaches. 28 Unfortunately these percutaneous approaches, enthusiastically adopted by radiologists and urologists, are limited by the composition of the stones when attempting dissolution, and the size and composition when attempting extraction in a dilated duct.28 These limitations led to the investigation of devices capable of destroying gall stones in situ, but even early reports with this type of equipment have indicated that significant morbidity might be expected. 29 The lack of a wholly successful treatment for gall stones in situ, combined with fears about long-term problems from damaged mucosa (both recurrent stone disease and malignancy) contributed to the enthusiasm with which laparoscopic cholecystectomy was greeted.
Laparoscopic cholecystectomy
Since its introduction in France by Phillippe Mouret in Lyon in 1987, laparoscopic cholecystectomy has emerged as an attractive alternative to traditional cholecystectomy for symptomatic gall stone disease. The main advantages of this technique are the cosmetic aspects, minimal wound pain with complete resolution within a few days, the short hospital stay, the ability of many patients to return to work within a week of operation'0 and the improvement of postoperative respiratory function compared to both classical"" 2 and 'mini-lap' cholecystectomies.33 Initially, the proportion ofpatients suitable for laparoscopic cholecystectomy was believed to be approximately 80% .34 However, with increasing experience the list of absolute contraindications has clearly diminished, making laparoscopic cholecystectomy suitable for nearly all patients Despite the rapid and widespread acceptance, early data suggest that some complications are more common after laparoscopic cholecystectomy when compared to traditional cholecystectomy. The main area of concern with this procedure is bile duct injury, and the experience from several institutions reporting an overall rate between 0.3% and 0.6%36-39 compared to only 0.1 % in patients with traditional cholecystectomy.40 It must be remembered, however, that the above figures are those for surgeons still familiarising themselves with the technique. Whether this risk translates into a significant problem with bile duct strictures or patients with long-term sequelae of undetected bile duct injuries remains to be seen. It is generally accepted that only fully trained general surgeons with expertise in biliary surgery and an adequate training in laparoscopy should perform laparoscopic cholecystectomy.4" With a background of previous similar discussions for flexible endoscopy, the Board ofDirectors of the Society of American Gastrointestinal Endoscopic Surgeons has introduced guidelines for Granting of Privileges for Laparoscopic General Surgery.42 In accordance with this and with a view to influencing the widespread adoption of this new procedure, clinical laparoscopic training has been introduced into general surgery residency programmes. 43 Finally, in the present era of National Health Service reforms and widespread redistribution of funds, the financial implications of laparoscopic cholecystectomy are clear with a cost-saving capital per patient (largely due to reduced hospital stay) of £900.'7 Utilising selection criteria which eliminate most high-risk patients it is estimated that 60% ofall patients undergoing laparoscopic cholecystectomy could be done as true out-patients leading to even less expense and greater convenience for the patient.'
Gall bladder carcinoma
The last 30 years has seen 41 studies ofgall bladder cancer appear in the literature to o oto hs giving details of almost 45 000 patients.
The motivation for most of these studies hinges not on the frequency of the tumour (which although the commonest biliary tract malignancy is still a rare tumour) but upon the dismal prognosis, irrespective of treatment, in all but the earliest lesions due to direct liver spread. The difficulty in achieving early detection of gall bladder cancer lies in the lack of any specific biochemical, clinical or radiological features. It is usually only advanced cases that present with suspicious symptoms (jaundice and unremitting pain), and 75% are found to be inoperable.86 Indeed the overall survival at between 0 and 12.5% at five years (median 1.7%) is only improved in those 15% of patients with tumours discovered incidentally subsequent to histological examination. stones. The incidence of carcinoma increases two-to four-fold for 2.0-2.9 cm stones compared to stones of 1 cm and increases 10-fold for stones greater than 3 cm.98 It has also been shown that cholesterol stones are most likely to be associated with the development of carcinoma. Despite the strong correlation between the two the causity of gall stones in the pathogenesis of gall bladder cancer is not yet fully understood. It is postulated that the chronic trauma and mucosal inflammation caused by gall stones lead to dysplasia and hence frank malignancy, with the accumulative risk of eventually developing carcinoma in a gall bladder containing stones estimated at 8% over the age of 50.9 These findings, together with work tracing the sequence from gall bladder adenoma to in situ malignancy,86 forms a basis for some reservations about the move away from traditional cholecystectomy.
The present position
The traditional upper abdominal cholecystectomy incision is unsightly, painful and associated with postoperative respiratory complications. Patients usually require a hospital stay of at least a week and full normal activity (particularly heavy manual work) is typically not restarted for several weeks. This latter problem infrequently produces considerable domestic and financial problems and is one of the main arguments in favour of the move to laparoscopic cholecystectomy. Whilst laparoscopic cholecystectomy is a new procedure which has a considerable way to go before its' place in the' surgical armamentarium is clearly defined,25""0' it nevertheless has clear advantages over traditional cholecystectomy. Further, unlike non-surgical options, removal of the gall bladder not only cures the disease, but at the same time eliminates the possibility ofrecurrence and the development ofcarcinoma due to diseased mucosa remaining in situ. The role of recurrent disease is indeed significant as, after destruction of stones or their removal, if follow-up is long enough, reformation occurs in about 66% of patients,'0' although bile salts and prostaglandin inhibitors seem to reduce this problem.'02 It seems reasonable to assume that this approach is likely to increase the risk of malignant transformation further by prolonging the period of chronic irritation. This has led to attempts to ablate the gall bladder mucosa by installation of a variety of agents after occlusion of the cystic duct'03 but this approach could have predictably disastrous consequences if the cystic duct were imperfectly occluded.
The simultaneous development of a number of completely different gall bladder preserving conservative approaches had many critics who were worried about the lack of long-term data. It is extremely unlikely that, had a 'multicentre study' been constructed in similar fashion, clinicians would have accepted it. Fortunately the emergence of laparoscopic cholecystectomy as a safe, simple procedure in confident hands is likely to redress the balance between nonoperative treatments and traditional cholecystectomy. 
